2022;14:e32248
A method of reversing, ameliroating or slowing progression of at least one symptom of Parkinson's disease in a patient in need thereof, comprising the step of administering to said patient an amount of one or more hepatocyte growth factor mimics sufficient to reverse, ameliorate or slow progression of said at least one symptom of Parkinson's disease, said one or more hepatocyte growth factor mimics having a general structural formula 1 2 3 wherein Ri is one of an N-acyl group, a substituted or unsubstituted phenyl, a norleucine group, and an amino acid selected from tyrosine, phenylalanine, aspartic acid, arginine, isoleucine, serine, histidine, glycine, cysteine, methionine, tryptophan, lysine norvaline, ornithine, and s-benzyl cysteine
HEALTHY CRAVING SUPPORT: Our GLP-1 gummies gummies are infused with Organic Ginseng, Green Tea, and Yerba Mate to help boost natural energy levels
Uric acid - key ingredient in the recipe for cardiorenal metabolic syndrome
The work was supported by the state task of the National Almazov Medical Research Center No